MACROGENICS INC
Datakwaliteit: 100%
MGNX
NASDAQ
Manufacturing
Chemicals
€ 3,41
▼
€ 0,11
(-3,13%)
6 months return
—
Momentum
Neutral
5Y revenue growth
17,87%
Groei
Revenue Growth (5Y)
17,87%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)-0,31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-131,35%
Onder sectorgemiddelde (-54,47%)
ROIC-26,60%
Net Margin-49,91%
Op. Margin-48,72%
Veiligheid
Debt / Equity
N/A
Current Ratio5,22
Interest Coverage-8,56
Waardering
PE (TTM|NTM)
-2,92 | -2,64
Onder sectorgemiddelde (-1,50)
P/B Ratio3,25
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 17,87% annually over 5 years — strong growth
Negative free cash flow of -82,95 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 18,18%
Capital efficient — spends only 1,28% of revenue on capex
Price History
Financiële Trends
Koersdoel Analisten
5 analisten
Buy
+40.8%
upside to target
Huidig
€ 3,41
Consensus Target
€ 4,80
€ 2,00
Laag
€ 9,00
Hoog
Vooruitzicht
Forward K/W
-2,64
Forward WPA
-€ 1,34
Omzet Sch.
98,54 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,57
·
Rev Est: 15,24 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -€ 0,65 | -€ 0,57 | € 0,27 | -€ 0,22 | — | — |
| Estimate | -€ 0,69 | € 0,38 | -€ 0,51 | -€ 0,02 | -€ 0,57 | -€ 0,57 |
| Verrassing | +5,80% | -250,00% | +153,47% | -1000,00% | — | — |
Growth
Rev 5Y: 17,87% · Earnings 1Y: N/A
Growth
Rev 5Y: 17,87% · Earnings 1Y: N/A| Revenue Growth (1Y) | -0,31% | Revenue Growth (3Y) | 59,52% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17,87% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -131,35% · Net Margin: -49,91%
Profitability
ROE: -131,35% · Net Margin: -49,91%| Revenue (TTM) | 149,50 M | Net Income (TTM) | -74,62 M |
| ROE | -131,35% | ROA | -28,91% |
| Gross Margin | N/A | Operating Margin | -48,72% |
| Net Margin | -49,91% | Free Cash Flow (TTM) | -82,95 M |
| ROIC | -26,60% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 5,22
Safety
D/E: N/A · Current: 5,22| Debt / Equity | N/A | Current Ratio | 5,22 |
| Interest Coverage | -8,56 | Asset Turnover | 0,58 |
| Working Capital | 187,62 M | Tangible Book Value | 67,00 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -2,92 · EV/EBITDA: N/A
Valuation
P/E: -2,92 · EV/EBITDA: N/A| P/E Ratio | -2,92 | Forward P/E | -2,64 |
| P/B Ratio | 3,25 | P/S Ratio | 1,46 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,21 | Fwd Earnings Yield | N/A |
| FCF Yield | -38,11% | ||
| Market Cap | 217,68 M | Enterprise Value | 137,55 M |
Per Share
EPS: -1,18 · FCF/Share: -1,31
Per Share
EPS: -1,18 · FCF/Share: -1,31| EPS (Diluted TTM) | -1,18 | Revenue / Share | 2,35 |
| FCF / Share | -1,31 | OCF / Share | -1,28 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 111,17% · CapEx/Rev: 1,28%
Efficiency
FCF Conv: 111,17% · CapEx/Rev: 1,28%| CapEx / Revenue | 1,28% | FCF Conversion | 111,17% |
| SBC-Adj. FCF | -100,55 M | Growth Momentum | -18,18 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 149,50 M | 149,96 M | 58,75 M | 151,94 M | 77,45 M |
| Net Income | -74,62 M | -66,97 M | -9,06 M | -119,76 M | -202,12 M |
| EPS (Diluted) | -1,18 | -1,07 | -0,15 | -1,95 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -72,84 M | -110,58 M | -168,24 M | -121,42 M | -202,80 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 147,17 M | 177,19 M | 166,58 M | 207,03 M | 214,58 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 7,17 M | 7,54 M | 9,65 M | 11,87 M | 11,26 M |
| Interest Expense | 8,51 M | 1,12 M | 1,43 M | — | — |
| Income Tax | -672.000,0 | 944.000,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 256,85 M | 261,66 M | 298,42 M | 280,47 M | 335,25 M |
| Total Liabilities | 201,26 M | 145,60 M | 145,81 M | 138,46 M | 95,63 M |
| Shareholders' Equity | 55,59 M | 116,06 M | 152,61 M | 142,01 M | 239,62 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 57,22 M | 182,84 M | 100,96 M | 108,88 M | 123,47 M |
| Current Assets | 219,94 M | 217,49 M | 251,34 M | 222,18 M | 279,56 M |
| Current Liabilities | 43,12 M | 55,53 M | 56,11 M | 48,61 M | 74,58 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,9 | -1,5 |
| P/B | 3,3 | 1,6 |
| ROE % | -131,4 | -54,5 |
| Net Margin % | -49,9 | -41,5 |
| Rev Growth 5Y % | 17,9 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"MGNX","listing_kind":"stock","pathname":"/stocks/mgnx","exchange":"NASDAQ","country":"US"}}